How effective is Tirosint for Hashimoto's Disease (Chronic thyroiditis)? (a real world drug study)
Summary:
Overall ratings: 3.6/5 Long term ratings: 3.6/5
This is a phase IV clinical study of how effective Tirosint (levothyroxine sodium) is for Hashimoto's disease and for what kind of people. The study is created by eHealthMe from 19 Tirosint users and is updated continuously.
What is Tirosint?
Tirosint has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. eHealthMe is studying from 5,001 Tirosint users. Check the latest studies of Tirosint.
What is Hashimoto's disease?
Hashimoto's disease (spectrum of autoimmune thyroid diseases (aitds) and is characterized by the destruction of thyroid cells) is found to be associated with 696 drugs and 1,093 conditions by eHealthMe. Check the latest studies of Hashimoto's disease.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
19 people are studied for taking Tirosint in Hashimoto's disease
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Tirosint effectiveness for Hashimoto's disease (number of people):
Overall:
- not at all: 0
- somewhat: 3
- moderate: 5
- high: 7
- very high: 4
Long Term:
- not at all: 0
- somewhat: 2
- moderate: 3
- high: 3
- very high: 3
Gender of people who take Tirosint for Hashimoto's disease *:
- female: 100 %
- male: 0.0 %
Age of people who take Tirosint for Hashimoto's disease *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 5.26 %
- 30-39: 26.32 %
- 40-49: 26.32 %
- 50-59: 26.32 %
- 60+: 15.79 %
Who find Tirosint more effective for Hashimoto's Disease?
Gender of people who take Tirosint for Hashimoto's disease *:
- female: 100 %
- male: 0.0 %
Age of people who take Tirosint for Hashimoto's disease *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 9.09 %
- 30-39: 27.27 %
- 40-49: 18.18 %
- 50-59: 27.27 %
- 60+: 18.18 %
* Approximation only. Some reports may have incomplete information.
Do you take Tirosint?
- You can start a phase IV clinical trial to monitor Tirosint safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
Alternative drugs to, pros and cons of:
- Tirosint (5,001 reports)
Treatments, associated drugs and conditions:
- Hashimoto's disease (13,328 reports)
How the study uses the data?
The study is based on levothyroxine sodium (the active ingredients of Tirosint) and Tirosint (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- How effective is Premarin for Menopause? - 4 seconds ago
- Could Zovirax cause Blood Urea Nitrogen/Creatinine Ratio Increased? - 4 seconds ago
- Cephalexin and Dexamethasone drug interactions for boys aged 10-19 - 4 seconds ago
- Drug interactions of Sonata and Axert - 5 seconds ago
- Could Levothroid cause Photosensitivity Reaction? - 5 seconds ago
- Lantus Solostar vs. Fortamet, side effect and effectiveness comparison - 8 seconds ago
- Ampyra and Slurred Speech for Women aged 50-59 - 23 seconds ago
- Ampyra and Language Impairment for Women aged 50-59 - 24 seconds ago
- Ampyra and Inability To Speak for Women aged 50-59 - 24 seconds ago
- Ampyra and Impairment Of Speech for Women aged 50-59 - 24 seconds ago